Spectral Medical: Developer Of FDA-Approved Toraymyxin™ ("PMX") For Treatment of Endotoxic Septic Shock
Dr. John A. Kellum (MD, MCCM) and Chris Seto, Chief Medical Officer and CEO respectively, at Spectral Medical Inc. (TSX: EDT), were guest speakers at Benzinga’s All Access On July 15th, 2022.
